Treatment of cytomegalovirus gastrointestinal ulceration in a heart transplant patient.
A 62-year-old man developed cytomegalovirus gastrointestinal infection associated with moderate cardiac rejection. The patient was successfully treated with a new therapeutic agent 9-(1,3-dihydroxy-2-proproxymethyl) guanine during maximal immunosuppression. The medication was well-tolerated, and the patient had an excellent response to therapy. We believe this has significant implications for cytomegalovirus-induced gastrointestinal disease in the heart transplant patient.